SonoSite 180
This article was originally published in The Gray Sheet
Executive Summary
Shipment of SonoSite, Inc.' s 5.4-pound, hand-carried, digital ultrasound system to hospitals worldwide commences Sept. 21. A 510(k) for the device cleared FDA on March 26 (1"The Gray Sheet" April 12, p. 21). The system, which sells for approximately $20,000, will be marketed in Japan by Olympus Optical Co., in Europe by Esaote S.p.A., and in the U.S. by PSS World Medical subsidiaries Diagnostic Imaging, Inc., for hospitals and diagnostic imaging centers, and Physician Sales and Service for distribution to physicians' offices. While the device is initially targeted for use in obstetric, gynecologic and abdominal imaging, the portable system will allow physicians to expand the routine use of ultrasound, SonoSite notes
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.